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This study aims to assess antimicrobial consumption in the pediatric department of a tertiary 
care public hospital in Zimbabwe. 
Clinical records of pediatric inpatients admitted to Harare Central Hospital over a 3-week 
period were reviewed prospectively. Antimicrobial consumption was described as days of 
therapy per 100 inpatient days (DOT/100 PD). Adherence of antimicrobial drug prescriptions 
to the National Guidelines was also evaluated. 
A total of 121 (93.1%) children were prescribed at least one antimicrobial out of 130 children 
admitted. The median age was 14 months (IQR: 3 – 48 months).  
Overall antimicrobial consumption was 155.4 DOT / 100 PD (95% CI 146-165.2). The most 
frequently prescribed antimicrobials were benzylpenicillin, gentamicin and ceftriaxone. 
Prescriptions were adherent to national guidelines in 57.7% of children.  
This study shows that there is high antimicrobial drug usage in hospitalized children in 








Antimicrobial resistance (AMR) threatens our ability to effectively treat bacterial infections 
and leading to higher morbidity, mortality and costs.1 One of the major drivers of AMR is 
inappropriate antimicrobial use.1 In pediatric care, antimicrobials are among the most 
frequently prescribed medications. However, data on antimicrobial consumption in low-
income settings are limited. Such data are crucially important to inform national action plans 
and antimicrobial stewardship programmes (ASPs).  
This study aims to assess antimicrobial consumption in the pediatric department of a tertiary 
care public hospitals in Zimbabwe as a starting point for improving prescribing in this patient 
population. 
 
Patients and methods  
Harare Central Hospital (HCH) is one of two public-sector general hospitals in Harare, 
Zimbabwe, with a catchment population of 1 million, mainly from low-income communities. 
The hospital also receives referrals of seriously ill patients from other parts of the country.  
Clinical records of pediatric inpatients admitted to two general pediatric wards at HCH over a 
3-week period (26.06.2018-17.07.2018) were reviewed prospectively on a daily basis by a 
researcher who was not involved in prescribing. Patients were followed during the course of 
their admission. Patient characteristics, prescribed antimicrobials and their indication were 
recorded. Antimicrobial consumption was described as days of therapy per 100 inpatient days 
(DOT/100 PD)2 with each antimicrobial contributing individually to the days of therapy. In 
addition, utilization patterns were analyzed according to age group. Prescribing was assessed 
against current Zimbabwe guidelines3. 
Following piloting, data were collected and entered into an electronic database using Open 
Data Kit (ODK 2.0, www.opendatakit.org). Data were analyzed using Stata/IC version 15 
(Stata-Corp, TX, USA). Medians, interquartile ranges and proportions were calculated.  
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The study was approved by the Ethics Committees of HCH, the Medical Research Council of 




Over the study period, 130 children were admitted to the two medical wards. The median 
duration of hospital stay was 5 days (interquartile range (IQR): 3 – 7 days).  More than half of 
the patients were boys, (80/130, 61.5%); median age was 14 months (IQR: 3 – 48 months); 13 
(10%) were neonates, 42 (32.3%) infants, 46 (35.4%) children aged 1-5 years and 29 (22.3%) 
older children (≥5 years). Seven (5.4%) children were diagnosed with tuberculosis and 7 
(5.4%) were HIV-infected. Four children died during the admission. The duration of follow-
up ranged from one to fifteen days. 
A total of 121 (93.1%) children were prescribed at least one antimicrobial. The total number 
of individual antimicrobials prescribed was 264. In 14 (11.6%) children, prescriptions were 
issued in the emergency department and immediately changed once the child was admitted to 
the ward. Antimicrobials were prescribed for the following most frequent clinical diagnoses: 
pneumonia (n=48, 39.7%), acute gastroenteritis (n=14, 11.6%), severe acute malnutrition 
(n=13, 10.7%), neonatal sepsis (n=12, 9.2%) and meningitis (n=7, 5.8%). The initial 
diagnosis was changed in 9/130 (6.9%) children. 
When considering antimicrobials that were prescribed for at least 24 hours, the median 
number of antimicrobials prescribed was 2 (range 14), with 101 (84%) of the pediatric 
population receiving combination therapy. Most children (n=113, 93.4%) received 
intravenous antimicrobials. 
The total number of inpatient days was 659 and a total 1024 DOT were prescribed (Table 1). 
Overall antimicrobial consumption was 155.4 DOT / 100 PD (95% CI 146-165.2). The DOT/ 
100 PD according to the different age groups were 157.4 (95%CI 125.7-194.7), 161 (145.4-
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177.8), 167.8 (95%CI 151.4-185.6) and 124.1 (95%CI 106.1-144.2) in neonates, infants, 
children aged 1-5 years and ≥5 years respectively. The most frequently prescribed 
antimicrobials were benzylpenicillin (n=68, 56.2%; 279 DOT), gentamicin (n=63, 52.1%; 253 
DOT) and ceftriaxone (n=60, 49.6%; 281 DOT). Prescribed antimicrobials varied by age 
group: benzylpenicillin was the most commonly prescribed antimicrobial in infants (n=39; 
72.2%) while older children were mostly prescribed ceftriaxone (n=21; 91.3%). 
Out of the 121 children receiving antimicrobials, adherence to guidelines could be evaluated 
in 111. Among those, 64 (57.7%) received antimicrobials according to national guidelines. 
Prescriptions were adherent to national guidelines in 11/13 (84.6%), 36/47 (76.6%), 5/14 
(35.7%) and 4/11 (33.3%) children diagnosed with severe acute malnutrition, pneumonia, 
acute gastroenteritis and neonatal sepsis. In children admitted with neonatal sepsis, non-
adherence (n=7/11, 64%) was mostly due to the prescribing of ceftriaxone or benzylpenicillin 
and gentamicin for late onset neonatal sepsis whilst the guidelines recommend cloxacillin and 
gentamicin. For acute gastroenteritis, most cases (n=8/14, 57%) of non-adherence were due to 
the concurrent administration of ceftriaxone and ciprofloxacin. Stratified by age, prescriptions 
were adherent with guidelines in 6 (50%) neonates, 26 (65%) infants, 26 (61.9%) children 1-5 
years old, and 6 (35.3%) children ≥5 years.  
 
Discussion  
We believe this is the first study to assess antimicrobial prescribing in pediatric inpatients in 
Zimbabwe as the country seeks to develop and implement its national action plan for 
combating AMR.4 The majority of children admitted to the general pediatric ward at HCH 
received antimicrobials leading to high antimicrobial usage of 155.4 DOT/ 100 PD. 
Antimicrobial usage was considerably higher than that seen in hospitalized children in high-
income countries where rates varied from 29 DOT/100 PD to 94 DOT/100 PD)2 and in other 
settings from Sub-Saharan Africa (114 and 67 DOT/100PD in South Africa and the Gambia, 
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respectively).5, 6 The higher antimicrobial usage in this study may be explained by an overall 
higher proportion of children being prescribed antimicrobials (93% vs 54% in the Gambia), 
by the inclusion of neonates, and more frequent prescription of antimicrobial combinations. 
This may also reflect the high burden of infectious diseases in this setting, and the limited 
diagnostics available to confirm or refute bacterial infections leading to a syndromic 
management approach.  
In this study, 93% of children admitted to hospital were prescribed at least one antimicrobial, 
which is comparable to data reported from South Africa, Ethiopia and Mozambique.6-8 
However, this is much higher than in Europe, where around 40% of children were on 
antimicrobials, perhaps due to high underlying infectious disease burden in Zimbabwe, 
increased supervision by senior pediatricians and better diagnostic capacity in high-income 
settings.9, 10 A high proportion (84%) of children in our study received combination therapy 
accounting for the high DOT/100 PD. 
Antimicrobial prescriptions adhered to national guidelines in 57.7% of cases, which is, 
slightly lower than in a referral hospital in Namibia (62%).11 This may be due to the very 
rapid turn-over of the junior doctors who are the frontline for admitting children from the 
emergency department, and senior supervision may frequently be overstretched and unable to 
give sufficient oversight where there is diagnostic uncertainty. The relatively high number of 
prescriptions in discordance with national guidelines in our study may also be explained by 
limited access to microbiology diagnostics resulting in reduced confidence in diagnoses. Lack 
of AMR surveillance may lead to the prescribing of broader spectrum antimicrobials (using a 
“just in case” strategy). This was reflected in the relatively high usage of ceftriaxone (42.6 
DOT/100PD) for a broad range of indications versus the more narrow range of indications 
recommended in the national guidelines.3 The absence of institutional policies on rational 
antimicrobial use together with insufficient knowledge and training on antimicrobial 
prescribing, and unavailability of guidelines at the point of care, may also explain the high 
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frequency of antimicrobial prescriptions, combination therapies with overlapping spectrum 
(such as ceftriaxone and ciprofloxacin) and non-adherence.  
This study is limited by the use of hospital records for recording prescriptions and diagnoses, 
making the findings dependent on the quality of documentation. Secondly, only two wards 
from a single hospital were evaluated over a 3-week period. However, the study was 
conducted in large referral hospital with high numbers of pediatric admissions and used a 
prospective follow-up strategy to ensure that all documented prescriptions are recorded. Also, 
any IV to oral switching of antimicrobials was not assessed. Overall though, we believe these 
findings are robust and represent the current standard of antimicrobial use among pediatric 
inpatients in Zimbabwe. 
In conclusion, this study shows that there is high antimicrobial drug usage in children at the 
level of a referral hospital in Zimbabwe. However, a considerable proportion of prescriptions 
are non-adherent with national guidelines which is perhaps not surprising given the lack of 
monitoring and ASPs within the hospital. These findings emphasize the need for effective 
ASPs in Zimbabwe and for strengthening diagnostic capacity in low-income settings.  
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